AU4015097A - Transdermal therapeutic system having an active compound combination comprising oestriol - Google Patents

Transdermal therapeutic system having an active compound combination comprising oestriol

Info

Publication number
AU4015097A
AU4015097A AU40150/97A AU4015097A AU4015097A AU 4015097 A AU4015097 A AU 4015097A AU 40150/97 A AU40150/97 A AU 40150/97A AU 4015097 A AU4015097 A AU 4015097A AU 4015097 A AU4015097 A AU 4015097A
Authority
AU
Australia
Prior art keywords
oestriol
active compound
therapeutic system
transdermal therapeutic
compound combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU40150/97A
Other versions
AU729898B2 (en
Inventor
Britta Von Kleinsorgen
Reinhard Von Kleinsorgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU4015097A publication Critical patent/AU4015097A/en
Application granted granted Critical
Publication of AU729898B2 publication Critical patent/AU729898B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Abstract

Disclosed is a transdermal therapeutical approach involving oestriol as an active substance, characterized in that oestriol is combined with one or more active substances.
AU40150/97A 1996-09-04 1997-08-13 Transdermal therapeutic system having an active compound combination comprising oestriol Ceased AU729898B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19635883 1996-09-04
DE19635883A DE19635883A1 (en) 1996-09-04 1996-09-04 Transdermal therapeutic system with an active ingredient combination containing estriol
PCT/EP1997/004392 WO1998009631A1 (en) 1996-09-04 1997-08-13 Transdermal therapeutical approach involving a combination of active substances containing oestriol

Publications (2)

Publication Number Publication Date
AU4015097A true AU4015097A (en) 1998-03-26
AU729898B2 AU729898B2 (en) 2001-02-15

Family

ID=7804611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40150/97A Ceased AU729898B2 (en) 1996-09-04 1997-08-13 Transdermal therapeutic system having an active compound combination comprising oestriol

Country Status (17)

Country Link
EP (1) EP0927036B9 (en)
JP (1) JP2000517324A (en)
KR (1) KR20010029451A (en)
CN (1) CN1228702A (en)
AT (1) ATE289818T1 (en)
AU (1) AU729898B2 (en)
CA (1) CA2261655A1 (en)
CZ (1) CZ70099A3 (en)
DE (2) DE19635883A1 (en)
ES (1) ES2239362T3 (en)
IL (1) IL128768A0 (en)
NO (1) NO991047L (en)
NZ (1) NZ334443A (en)
PL (1) PL332035A1 (en)
SK (1) SK25299A3 (en)
WO (1) WO1998009631A1 (en)
ZA (1) ZA977895B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2233142A4 (en) 2007-12-10 2011-01-05 Cosmed Pharmaceutical Co Ltd Transdermally absorptive preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
KR100240358B1 (en) * 1991-02-26 2000-02-01 제이코버스 코넬리스 레이서 Method for the treatment of osteoporosis
WO1993018774A1 (en) * 1992-03-21 1993-09-30 Entec Gesellschaft Für Endokrinologische Technologie M.B.H. Use if estriol for treating climacteric osteoporosis
JPH0679002A (en) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc Patch device for percutaneous administration
DE4405898A1 (en) * 1994-02-18 1995-08-24 Schering Ag Transdermal therapeutic systems containing sex steroids

Also Published As

Publication number Publication date
NO991047D0 (en) 1999-03-03
IL128768A0 (en) 2000-01-31
DE59712215D1 (en) 2005-04-07
EP0927036A1 (en) 1999-07-07
PL332035A1 (en) 1999-08-16
NZ334443A (en) 1999-08-30
WO1998009631A1 (en) 1998-03-12
NO991047L (en) 1999-03-03
JP2000517324A (en) 2000-12-26
DE19635883A1 (en) 1998-03-05
ZA977895B (en) 1998-03-02
CZ70099A3 (en) 1999-07-14
EP0927036B1 (en) 2005-03-02
CN1228702A (en) 1999-09-15
ATE289818T1 (en) 2005-03-15
CA2261655A1 (en) 1998-03-12
AU729898B2 (en) 2001-02-15
SK25299A3 (en) 2000-08-14
EP0927036B9 (en) 2005-08-10
KR20010029451A (en) 2001-04-06
ES2239362T3 (en) 2005-09-16

Similar Documents

Publication Publication Date Title
AU676826B2 (en) Transdermal therapeutic systems
AU4894197A (en) Syringe, injector and injector system
AU3593597A (en) Medical adhesive bandage, delivery system and method
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
EP0935415A4 (en) Methods for delivering compounds into a cell
AU2263197A (en) Diabetes therapy
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
AU3945295A (en) Improved dual-chamber syringe & methods
AU4950493A (en) Transdermal application agent containing 3-keto-desogestrel
AU1525797A (en) Two-stage angled venous cannula
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU3378297A (en) Blood treatment system
AU7840994A (en) Active substance delivery system
AU3592897A (en) Toxins active against pests
AU2337897A (en) Uniform drug delivery therapy
AU2508597A (en) Drug for the treatment of tumours
EP0679402A3 (en) Biologically active substance-secreting hybrid gel.
AU7313896A (en) Pharmaceutical composition containing an activin or inhibin stimulator
WO1997030714A3 (en) Topical pharmaceutical composition containing heparin
AU7552098A (en) Physiologically active substances tkr2449, process for producing the same, and microorganism
ZA96796B (en) Transdermal formulation.
AU6617798A (en) Extensible transdermal therapeutic system
AU2187197A (en) Transdermally administered acetylcysteine as mucolytic agent
AU8099794A (en) Piercing thermal therapy catheter

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired